-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
2026-04-03
Shijiazhuang Institute of Science and Technology Conducts Enterprise Visit and Job-Expansion Activities at Shijiazhuang Sihua Pharmaceutical Group
Recently, Zhang Hui, Vice President of Shijiazhuang Institute of Science and Technology and Director of the Department of Pharmaceutical Engineering, led a delegation to Shijiazhuang Sihua Pharmaceutical Group to carry out a targeted enterprise visit and job-expansion initiative aimed at boosting employment.
2026-03-27
Shijiazhuang Sihua Pharmaceutical Group Makes Its Debut at the 2026 South Africa Pharmaceutical Exhibition, Actively Expanding into the African Market
From March 25 to 26 local time, the 2026 South African Pharmaceutical Exhibition (SAPHEX) was held at the Sandton Convention Centre in Johannesburg. The foreign trade team of Shijiazhuang Sihua Pharmaceutical Group showcased bulk specialty APIs and its competitive finished dosage forms at the exhibition, actively seeking to expand into the African pharmaceutical market.
2026-03-20
Shijiazhuang Sihua Pharmaceutical: Intellectual Property Authorities Visit Enterprises to Facilitate the Alignment of Patent Navigation Outcomes, Providing Precise Support for Corporate Innovation
3月17日，为深入落实创新驱动发展战略，推动知识产权深度赋能产业创新，石家庄市市场监督管理局联合河北省知识产权保护中心、国家知识产权局专利局专利审查协作天津中心，走进石家庄四药举办专利导航成果推介及座谈交流会。此次活动搭建起专业审查、政务服务与企业创新的对接桥梁，助力企业进一步明晰研发方向、优化专利布局，为企业高质量发展注入知识产权动能。
On the afternoon of March 18, at the MDS 2026 Fourth Pharmaceutical Marketing Big Data Summit held in the mountain city of Chongqing, Zhongmeng Big Data and Yaozhi Network jointly released the 2025 Top 100 Chinese Pharmaceutical Companies Ranking and simultaneously unveiled the China Pharmaceutical Retail Rankings. Shijiazhuang Sihua Pharmaceutical Group, thanks to its sustained and steady market influence, was successfully included in the 2025 Chinese Pharmaceutical Market Rankings series, ranking 66th on the Overall List and 27th on the Chemical Pharmaceuticals List.
19
2026/03
The 11th Members’ Congress of Shijiazhuang Sihua Pharmaceutical Co., Ltd. Concludes Successfully
On March 14, the 11th Congress of Members of Shijiazhuang Sihua Pharmaceutical Co., Ltd. was held. The meeting was guided by Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, thoroughly studied and implemented the spirit of the 20th National Congress of the Communist Party of China and all plenary sessions of the 20th CPC Central Committee, comprehensively summarized the trade union’s achievements and experiences over the past five years, outlined the main tasks for the next five years, elected a new trade union committee, and mobilized all employees to further emancipate their minds, strive vigorously, and work hard to accelerate the company’s high-quality development. Wu Hengyao, Shi Jianhui, Huang Xiaofeng, Zhang Wenya, and Liu Jing, members of the Presidium, together with 90 trade union member representatives from various workshops and departments, gathered at the event.
14
2026/03
On March 13, Shijiazhuang Sihua Pharmaceutical Group’s sodium chloride injection (3000 ml: 27 g) submitted a related application that designated the three-layer co-extruded infusion tubing manufactured by its subsidiary, Jiangsu Bosheng Medical New Materials Co., Ltd., as the pharmaceutical packaging material, and subsequently received formal approval from the National Medical Products Administration in the form of a supplemental drug application. This approval signifies that the critical pharmaceutical packaging material associated with this product—the three-layer co-extruded infusion tubing—has, for the first time, achieved domestic substitution.
14
2026/03
On March 11, a delegation led by Fan Qingshu, Vice President of the Hebei Tsinghua Institute for Development, and Li Ping, Director of the Management Center of the Yanzhao Biopharmaceutical Laboratory, visited the Pharmaceutical Research Institute of Shijiazhuang Sihua Pharmaceutical Group for in-depth discussions on deepening cooperation in innovation and development. Sun Lijie, Executive President of the Group and Director of the Pharmaceutical Research Institute (General Manager of the R&D Center), along with Executive President Tian Pengmei, attended the meeting.
12
2026/03
On March 6, the Cangzhou Lingang Economic and Technological Development Zone held a mobilization conference and summary-and-award ceremony for high-quality development in 2026, at which enterprises that have made outstanding contributions to the zone’s high-quality development were solemnly commended. Hebei Guangxiang Pharmaceutical Co., Ltd. of Shijiazhuang Sihua Pharmaceutical Group was awarded the “Leading Enterprise Award for Scientific and Technological Innovation” in recognition of its exceptional performance in the field of scientific and technological innovation.
09
2026/03
Shijiazhuang Sihua Pharmaceutical Group Makes Its Debut at the 2026 Natural Products Expo West
From March 4 to 6 local time, the 2026 Natural Products Expo West was held at the Anaheim Convention Center in California. The API export team of Shijiazhuang Sihua Pharmaceutical Group showcased its competitive, specialty API products at the exhibition, actively pursuing opportunities in the North American and global markets.
09
2026/03
On February 27, the Office for the Follow-up Procurement of Drugs Whose National Centralized Procurement Agreements Have Expired announced the results of the follow-up procurement (LC-YPJX-2026-1) for drugs whose national centralized procurement agreements have expired, revealing that Shijiazhuang No.4 Pharmaceutical Co., Ltd. had 45 drug varieties and 55 specifications selected.
09
2026/03
On February 28, the Shijiazhuang High-tech Industrial Development Zone held a conference on high-quality development, sounding the resounding call to sprint from the very start of the year. During the event, a list of enterprises that have made outstanding contributions to promoting the zone’s high-quality development was announced and commended, with Shijiazhuang Sihua Pharmaceutical honored with three prestigious awards: Industry Leader Enterprise, Innovation Demonstration Enterprise, and one of the Top Ten Taxpayers of the Year.
09
2026/03
On February 26 (the tenth day of the first lunar month), the CPC Xinghua Municipal Committee and the Xinghua Municipal People’s Government convened a citywide conference on high-quality industrial development. Grounded in the new starting point of the 15th Five-Year Plan period, the conference aimed to rally the concerted efforts of government and enterprises and unite the entire population in a spirit of vigorous striving, so as to propel enterprise development to take the lead and maintain continuous progress, thereby helping Xinghua achieve new heights in its drive for high-quality development. During the conference, outstanding enterprises and exemplary projects that emerged across the city in 2025 were solemnly commended. Shijiazhuang Sihua Pharmaceutical Group Jiangsu Bosheng Medical New Materials Co., Ltd. was honored with two prestigious awards—the “Outstanding Taxpayer Enterprise” and the “Top Ten Enterprises for Technological Innovation”—in recognition of its remarkable contributions and robust innovation capabilities.
28
2026/02
On February 24, researchers at the Pharmaceutical Research Institute of Shijiazhuang Sihua Pharmaceutical Group were stepping up experimental work on the development of new products.
25
2026/02
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091